肿瘤坏死因子α在系统性红斑狼疮中的作用及肿瘤坏死因子阻断治疗的潜在益处：对皮塞茨基社论的评论 - Suppr | 超能文献

Role of tumor necrosis factor alpha and potential benefit of tumor necrosis factor blockade treatment in systemic lupus erythematosus: comment on the editorial by Pisetsky.

作者信息

Aringer M, Steiner G, Graninger W, Smolen J

出版信息

Arthritis Rheum. 2001 Jul;44(7):1721-2. doi: 10.1002/1529-0131(200107)44:7<1721::AID-ART302>3.0.CO;2-J.

DOI:10.1002/1529-0131(200107)44:7<1721::AID-ART302>3.0.CO;2-J

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Role of tumor necrosis factor alpha and potential benefit of tumor necrosis factor blockade treatment in systemic lupus erythematosus: comment on the editorial by Pisetsky.肿瘤坏死因子α在系统性红斑狼疮中的作用及肿瘤坏死因子阻断治疗的潜在益处：对皮塞茨基社论的评论

Arthritis Rheum. 2001 Jul;44(7):1721-2. doi: 10.1002/1529-0131(200107)44:7<1721::AID-ART302>3.0.CO;2-J.

2

On anti-tumor necrosis factor-induced systemic lupus erythematosus.关于抗肿瘤坏死因子诱导的系统性红斑狼疮。

J Rheumatol. 2010 Jan;37(1):3-5. doi: 10.3899/jrheum.091071.

3

Regression of subacute cutaneous lupus erythematosus in a patient with rheumatoid arthritis treated with a biologic tumor necrosis factor alpha-blocking agent: comment on the article by Pisetsky and the letter from Aringer et al.一名类风湿关节炎患者使用生物肿瘤坏死因子α阻断剂治疗后亚急性皮肤型红斑狼疮消退：对皮塞茨基文章及阿林格等人来信的评论

Arthritis Rheum. 2002 May;46(5):1408-9; author reply 1409. doi: 10.1002/art.10271.

4

Breaking the ice: Testing tumor necrosis factor alpha blockade in lupus.打破僵局：狼疮中肿瘤坏死因子α阻断疗法的试验

Arthritis Rheum. 2004 Oct;50(10):3061-3. doi: 10.1002/art.20577.

5

The possible role of tumor necrosis factor (TNF) and its natural inhibitors, the soluble-TNF receptors, in autoimmune diseases.肿瘤坏死因子（TNF）及其天然抑制剂可溶性TNF受体在自身免疫性疾病中可能发挥的作用。

Isr J Med Sci. 1992 Feb;28(2):126-30.

6

Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study.肿瘤坏死因子α阻断剂治疗系统性红斑狼疮的安全性和有效性：一项开放标签研究。

Arthritis Rheum. 2004 Oct;50(10):3161-9. doi: 10.1002/art.20576.

7

Photosensitivity in lupus erythematosus.红斑狼疮中的光敏性。

Photodermatol Photoimmunol Photomed. 2004 Oct;20(5):272-9. doi: 10.1111/j.1600-0781.2004.00094.x.

8

Drug-induced lupus: Including anti-tumour necrosis factor and interferon induced.药物性狼疮：包括抗肿瘤坏死因子和干扰素诱导的狼疮。

Lupus. 2014 May;23(6):545-53. doi: 10.1177/0961203314523871. Epub 2014 Feb 20.

9

Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.埃及女性系统性红斑狼疮患者的血清新蝶呤、肿瘤坏死因子-α及可溶性肿瘤坏死因子受体II（p75）水平与疾病活动度

Clin Biochem. 2005 Feb;38(2):134-41. doi: 10.1016/j.clinbiochem.2004.11.002.

10

[Clinical and pathogenic significance of tumor necrosis factor-alpha in systemic lupus erythematosus].肿瘤坏死因子-α在系统性红斑狼疮中的临床及致病意义

Ter Arkh. 2002;74(5):32-5.

引用本文的文献

1

Metabolic Analysis of Potential Key Genes Associated with Systemic Lupus Erythematosus Using Liquid Chromatography-Mass Spectrometry.基于液相色谱-质谱联用的系统性红斑狼疮潜在关键基因的代谢分析。

Comput Math Methods Med. 2021 Oct 4;2021:5799348. doi: 10.1155/2021/5799348. eCollection 2021.

2

CKD-506, a novel HDAC6-selective inhibitor, improves renal outcomes and survival in a mouse model of systemic lupus erythematosus.新型 HDAC6 选择性抑制剂 CKD-506 改善系统性红斑狼疮小鼠模型的肾脏结局和生存率。

Sci Rep. 2018 Nov 23;8(1):17297. doi: 10.1038/s41598-018-35602-1.

3

Therapy of systemic lupus erythematosus: a look into the future.系统性红斑狼疮的治疗：展望未来。

Arthritis Res. 2002;4 Suppl 3(Suppl 3):S25-30. doi: 10.1186/ar579. Epub 2002 May 9.